| Blueprint ID | Learning Objectives |
| 8347 | Define epidemiology and be familiar with its history and current applications. |
| 8348 | Define the epidemiological triad. |
| 8349 | Identify and define the range of measures used to describe disease and health in a community. |
| 8350 | Demonstrate understanding of the uses, strengths and limitations of the measures of disease frequency. |
| 8351 | Describe the relationship between incidence, prevalence and duration and know how to use these concepts |
| 8352 | Describe the difference between crude and adjusted rates. |
| 8353 | Construct 2x2 tables and calculate relative risk measures |
| 8354 | Identify, define and calculate the common measures of association used in epidemiology (risk difference, attributable risk exposed, population attributable risk, relative risk, odds ratios). |
| 8355 | Define and interpret confidence intervals. |
| 8356 | Differentiate between descriptive and analytic study designs in epidemiology. |
| 8357 | Identify and describe basic study designs used in epidemiological investigations and describe their advantages and disadvantages (including biases and measures used to minimize them) |
| 8358 | Identify ethical considerations for epidemiologic studies. |
| 8359 | Identify the measures of risk associated with each of the basic study designs. |
| 8360 | Define bias and confounding. |
| 8361 | Differentiate between screening and diagnostic tests and identify the criteria used to evaluate them |
| 8362 | Define accuracy and precision. |
| 8363 | Calculate sensitivity, specificity, positive and negative predictive values of tests and interpret the results as they apply to screening and diagnoses. |
| 8364 | Demonstrate an understanding of the principles underlying screening programs, including their ethical issues. |
| 10220 | Describe the difference between accuracy and precision. |
| 10221 | Calculate Cohen’s Kappa and interpret the result as it applies to the comparison of two tests. |
| 10222 | Derive median survival and estimated survival times from Kaplan-Meier curves |
| 10223 | Differentiate between analytic study designs and randomized control trials in epidemiology. |
| 10224 | Identify and describe randomized control design and describe the advantages and disadvantages of this design. |
| 10225 | Identify ethical considerations for randomized control trials. |
| 10226 | Identify the requirement for randomization and blinding. |
| 10227 | Appraise biases that can occur in RCT |
| 10228 | Differentiate between intention to treat and per protocol designs. |
| |